General Brain Cancer

Novel Vaccine Prolongs Survival in Glioblastoma Multiforme (12-20-2013)

Eight of 16 patients with glioblastoma multiforme who participated in a vaccine study survived longer than fiver years after diagnosis, according to the results of a study presented at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology. Glioblastoma... Continue Reading

No Added Toxicity with Avastin in Glioblastoma (10-9-2013)

The addition of Avastin® (bevacizumab) to standard chemoradiation significantly slowed the progression of glioblastoma without added toxicity, according to the results of a study presented at the annual meeting of the American Society of Radiation Oncology. Glioblastoma... Continue Reading

Antiviral Drug May Extend Survival in Glioblastoma (09-25-2013)

The common antiviral drug Valcyte (valganciclovir) may extend survival in glioblastoma, according to the results of a study published in the New England Journal of Medicine. Glioblastoma is one of the most common and fatal types of primary brain cancer.... Continue Reading

Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma (06-7-2013)

In a Phase III clinical trial among patients with newly diagnosed glioblastoma, the addition of Avastin® (bevacizumab) to standard chemoradiation increased side effects and did not improve overall survival. These results were presented at the 2013 Annual... Continue Reading

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (05-22-2013)

Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) — Agenus Inc. (Nasdaq:AGEN)... Continue Reading

Early Resection of Low-Grade Gliomas Improves Survival (11-21-2012)

Patients in Norway with low-grade gliomas who were treated with early surgical resection had better overall survival than those treated with biopsy and watchful waiting, according to the results of a study published in the Journal of the American Medical... Continue Reading

Repeated Surgeries Improve Survival in Glioblastoma (11-13-2012)

Patients with recurrent glioblastoma who undergo multiple surgeries to remove tumors may survive longer than those who undergo only one surgery, according to the results of a study published in the Journal of Neurosurgery. Glioblastoma mutiforme (GBM)... Continue Reading

Chemotherapy Plus Radiation Improves Survival for Anaplastic Oligodendroglioma (10-29-2012)

Some patients with anaplastic oligodendroglioma live substantially longer if they are treated with a combination of chemotherapy and radiation instead of radiation alone, according to the long-term results of two studies published in the Journal of Clinical... Continue Reading

Temodar and Hypofractionated Radiotherapy Appropriate for Elderly Patients with Glioblastoma (08-21-2012)

Both Temodar® (temozolomide) and hypofractionated radiotherapy should be considered as standard treatment options in elderly patients with glioblastoma, according to the results of a study published in the Lancet Oncology. Glioblastoma multiforme (GBM)... Continue Reading

Childhood CT Scans Linked to Leukemia and Brain Cancer Later in Life (06-20-2012)

Children and young adults who undergo multiple computed tomography (CT) scans have an increased risk of leukemia and brain tumors in the decade following their first scan, according to the results of a study published in The Lancet. CT scans are a common... Continue Reading

« Previous PageNext Page »